Agape ATP (ATPC) 10-K/A 18 May 22 2021 FY Annual report (amended) Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 23, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	Agape ATP Corporation (the “Company,” “we”, “our” or “us”) is filing this Amendment No. 1 to its Annual Report on Form 10-K/A (the “Amendment”), to amend its Annual Report on Form 10-K for the year ended December 31, 2021, originally filed with the Securities and Exchange Commission (the “SEC”), on March 28, 2022 (the “Original Filing”), to include an assessment and effectiveness conclusion regarding disclosure controls and procedures to Item 9A.
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2021
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Entity File Number	333-220144
Entity Registrant Name	AGAPE ATP CORPORATION
Entity Central Index Key	0001713210
Entity Tax Identification Number	36-4838886
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	Tower 2
Entity Address, Address Line Two	Faber Towers
Entity Address, Address Line Three	Jalan Desa Bahagia
Entity Address, City or Town	Kuala Lumpur
Entity Address, Country	MY
Entity Address, Postal Zip Code	58100
City Area Code	(60)
Local Phone Number	192230099
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 914,950,575
Entity Common Stock, Shares Outstanding		75,452,012
Auditor Name	Friedman LLP
Auditor Firm ID	711
Auditor Location	New York, New York

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash and cash equivalents (Included $17,493 and $37,387 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)	$ 2,597,848	$ 3,517,600
Accounts receivable		172,757
Amount due from related parties	7,004	3,235
Inventories	375,535	589,814
Prepaid taxes (Included $1,357 and $11,330 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of December 31, 2021 and 2020, respectively.)	636,218	1,104,495
Prepayments and deposits	295,517	296,370
Total Current Assets	3,912,122	5,684,271
OTHER ASSETS
Property and equipment, net	215,799	298,309
Intangible assets, net	3,660	5,826
Operating right-of-use assets	237,718	394,141
Investment in marketable securities	89,001	577,035
Investment in non-marketable securities	1,500	1,500
Deferred offering costs	264,735	249,525
Total other assets	812,413	1,526,336
TOTAL ASSETS	4,724,535	7,210,607
CURRENT LIABILITIES
Accounts payable	13,715
Customer deposits	279,689	236,134
Operating lease liabilities	157,094	154,276
Other payables and accrued liabilities ($1,548 and $1,904 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of December 31, 2021 and 2020, respectively.)	858,355	647,677
Income tax payable	3,988
Amount due to a related party		455
Total Current Liabilities	1,312,841	1,038,542
NON-CURRENT LIABILITIES
Operating lease liabilities	83,484	241,488
Deferred tax liabilities	15,574	5,743
Total Non-current Liabilities	99,058	247,231
TOTAL LIABILITIES	1,411,899	1,285,773
STOCKHOLDERS’ EQUITY
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding
Common Stock, par value $0.0001; 1,000,000,000 shares authorized, 290,460,047 and 376,452,047 shares issued and outstanding as of December 31, 2021 and 2020, respectively.	29,046	37,645
Additional paid in capital	6,449,215	6,440,616
Accumulated deficit	(3,258,687)	(734,443)
Accumulated other comprehensive income	93,398	181,016
TOTAL AGAPE CORPORATION STOCKHOLDERS’ EQUITY	3,312,972	5,924,834
NON-CONTROLLING INTERESTS	(336)
TOTAL EQUITY	3,312,636	5,924,834
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 4,724,535	$ 7,210,607

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
VIE consolidated amount of cash and cash equivalents	$ 17,493	$ 37,387
VIE consolidated amount of prepaid taxes	1,357	11,330
VIE consolidated amount of other payables and accrued liabilities	$ 1,548	$ 1,904
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	200,000,000	200,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	290,460,047	376,452,047
Common stock, shares outstanding	290,460,047	376,452,047

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
REVENUE	$ 1,016,962	$ 3,434,561
REVENUE – RELATED PARTY		18,060
TOTAL REVENUE	1,016,962	3,452,621
COST OF REVENUE	(297,333)	(775,855)
GROSS PROFIT	719,629	2,676,766
SELLING	(394,682)	(376,582)
COMMISSION	(316,267)	(830,659)
GENERAL AND ADMINISTRATIVE	(1,745,734)	(1,627,660)
PROVISION FOR DOUBTFUL ACCOUNTS	(121,514)
TOTAL OPERATING EXPENSES	(2,578,197)	(2,834,901)
LOSS FROM OPERATIONS	(1,858,568)	(158,135)
OTHER (EXPENSES) INCOME
Other (Expenses) Income, net	(42,753)	164,283
Unrealized holding (loss) gain on marketable securities	(505,231)	350,137
Dividend income from marketable securities	18,939	160,062
TOTAL OTHER (EXPENSES) INCOME, NET	(529,045)	674,482
(LOSS) INCOME BEFORE INCOME TAXES	(2,387,613)	516,347
PROVISION FOR INCOME TAXES	(137,067)	(161,581)
NET (LOSS) INCOME	(2,524,680)	354,766
NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS	436
NET (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION	(2,524,244)	354,766
NET (LOSS) INCOME	(2,524,680)	354,766
OTHER COMPREHENSIVE (LOSS) INCOME
Foreign currency translation adjustment	(87,615)	171,231
TOTAL COMPREHENSIVE (LOSS) INCOME	(2,612,295)	525,997
Less: Comprehensive loss attributable to non-controlling interests	(433)
COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO AGAPE ATP CORPORATION	$ (2,611,862)	$ 525,997
(LOSS) EARNINGS PER SHARE
Basic and diluted	$ (0.01)	$ 0
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
Basic and diluted	376,216,452	376,387,778

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 37,628	$ 5,293,082	$ (1,089,209)	$ 9,785		$ 4,251,286
Shares, Outstanding, Beginning Balance at Dec. 31, 2019	376,275,500
Net income (loss)			354,766			354,766
Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd	$ 17	1,147,534				1,147,551
Stock Issued During Period, Shares, New Issues	176,547
Foreign currency translation adjustment				171,231		171,231
Ending balance, value at Dec. 31, 2020	$ 37,645	6,440,616	(734,443)	181,016		5,924,834
Shares, Outstanding, Ending Balance at Dec. 31, 2020	376,452,047
Net income (loss)			(2,524,244)		(436)	(2,524,680)
Foreign currency translation adjustment				(87,618)	3	(87,615)
Forfeiture of common stock	$ (8,599)	8,599
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited	(85,992,000)
Contributions from non-controlling interest shareholders					97	97
Ending balance, value at Dec. 31, 2021	$ 29,046	$ 6,449,215	$ (3,258,687)	$ 93,398	$ (336)	$ 3,312,636
Shares, Outstanding, Ending Balance at Dec. 31, 2021	290,460,047

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$ (2,524,680)	$ 354,766
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation	75,797	55,407
Amortization	1,961	1,505
Amortization of operating right-of-use assets	139,451	106,561
Unrealized holding loss (gain) on marketable securities	505,231	(350,137)
Dividend income from marketable securities	(18,939)	(160,062)
Deferred tax expense	10,127	178,329
Inventory write-down	36,241
Provision for doubtful accounts	121,514
Changes in operating assets and liabilities:
Accounts receivables	167,566	(165,149)
Amount due from a related party		(2,417)
Inventories	192,713	78,674
Prepaid taxes	430,062	184,985
Prepayments and deposits	(128,363)	352,577
Accounts payable		(2,804)
Customer deposits	52,981	(1,421,886)
Other payables and accrued liabilities	226,651	336,709
Operating lease liabilities	(138,143)	(105,009)
Income tax payables	3,988
Net cash used in operating activities	(845,842)	(557,951)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(3,959)	(4,734)
Purchase of intangible assets		(178)
Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd		1,210,818
Proceeds from sale of marketable securities		121
Proceeds from sale of non-marketable securities to a related party		70,173
Net cash (used in) provided by investing activities	(3,959)	1,276,200
CASH FLOWS FROM FINANCING ACTIVITIES:
Deferred offering costs	(15,210)	(249,525)
(Advances to) Repayments from related parties	(3,851)	227,434
Net cash used in financing activities	(19,061)	(22,091)
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS	(50,890)	76,985
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(919,752)	773,143
CASH AND CASH EQUIVALENTS, beginning of year	3,517,600	2,744,457
CASH AND CASH EQUIVALENTS, end of year	2,597,848	3,517,600
SUPPLEMENTAL CASH FLOWS INFORMATION
Income taxes paid	326,838	288,929
Interest paid
SUPPLEMENTAL NON-CASH FLOWS INFORMATION
Changes in right-of-use assets and lease liabilities due to lease modifications	3,250
Initial recognition of right-of-use assets and lease liabilities		483,343
Sale of non-marketable securities to a related party in exchange for acquisition payment of ASL		656,495
Issuance of common stock in exchange for acquisition payment of ASL		$ 1,147,551

ORGANIZATION AND BUSINESS BACKG

ORGANIZATION AND BUSINESS BACKGROUND	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
ORGANIZATION AND BUSINESS BACKGROUND	1. ORGANIZATION AND BUSINESS BACKGROUND Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016. Agape ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation, a company incorporated in Labuan, Malaysia, and Agape Superior Living Sdn. Bhd. (“ASL”), a company incorporated in Malaysia. . Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100 On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 99.99 Agape Superior Living Sdn. Bhd. is a limited company incorporated on August 8, 2003, under the laws of Malaysia. On September 11, 2020, the Company incorporated Wellness ATP International Holdings Sdn, Bhd. (“WATP”), a wholly owned subsidiary under the laws of Malaysia, to pursue the business of promoting wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns on how to achieve positive wellness and lifestyle. On November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60 . The Company and its subsidiaries are principally engaged in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. The accompanying consolidated financial statements reflect the activities of the Company, AATP LB, AATP HK, WATP, ASL and its variable interest entity (“VIE”), Agape S.E.A. Sdn. Bhd. (“SEA”) (See Note 3), and DSY Wellness. Details of the Company’s subsidiaries: SCHEDULE OF SUBSIDIARIES AND ASSOCIATES Subsidiary company name Place and date of incorporation Particulars of issued capital Principal activities Proportional of ownership interest and voting power held 1. Agape ATP Corporation Labuan, 100 shares of ordinary share of US$1 each Investment holding 100 % 2. Agape ATP International Holding Limited Hong Kong, 1,000,000 shares of ordinary share of HK$1 each Wholesaling of health and wellness products; and health solution advisory services 100 % 3. Agape Superior Living Sdn. Bhd. Malaysia, 9,590,598 shares of ordinary share of RM1 each Health and wellness products and health solution advisory services via network marketing 99.99 % 4. Agape S.E.A. Sdn. Bhd. Malaysia, 2 shares of ordinary share of RM1 each VIE of Agape Superior Living Sdn. Bhd. VIE 5. Wellness ATP International Holdings Sdn, Bhd Malaysia, 100 shares of ordinary share of RM1 each The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns 100 % 6. DSY Wellness International Sdn Bhd. Malaysia, 1,000 shares of ordinary share of RM1 each Provision of complementary health therapies 60 % AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 1. ORGANIZATION AND BUSINESS BACKGROUND (CONT’D) Business Overview Agape ATP Corporation is a company that provides health and wellness products and health solution advisory services to our clients. The Company primarily focus its efforts on attracting customers in Malaysia. Its advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians. In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99 Via ASL, the Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE. The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors. The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser. The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual. The Company deems creating public awareness on wellness and wellbeing lifestyle as essential to enhance the provision of its health solution advisory services; and therefore, incorporated WATP. Upon its establishment, WATP started collaborating with ASL to carry out various wellness programs. To further its reach in the Health and Wellness Industry, on November 11, 2021, Agape ATP Corporation (Labuan) formed a joint-venture entity, DSY Wellness International Sdn. Bhd. (“DSY Wellness”) with an independent third party which Agape ATP Corporation (Labuan) owns 60% of the equity interest, to pursue the business of providing complementary health therapies . AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares)

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”). The consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation. Principles of consolidation Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors. A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE. Use of estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates. Cash and cash equivalents Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) Accounts receivable Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, no Inventories Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net realizable value. For the years ended December 31, 2021, and 2020, the company recorded $ 36,241 0 Prepaid taxes Prepaid taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax . Prepayments and deposits Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, there was $ 121,514 0 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) Property and equipment, net Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows: SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT Useful Life Computer and office equipment 5 7 Furniture & fixtures 6 7 Leasehold improvements Lease Term Vehicle 5 The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives. Intangible assets, net Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows: SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET Classification Useful Life Computer software 5 Impairment for long-lived assets Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and 2020, no Deferred offering costs Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering. Investment in marketable equity securities The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities . AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) Investment in non-marketable equity securities The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount. Customer deposits Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy. Revenue recognition The Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products. The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) Sales of Health and Wellness products - Performance obligations satisfied at a point in time The Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns . The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $ 15,209 170,431 As of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $ 183,816 Sales of Health and Wellness services - Performance obligations satisfied at a point in time The Company carries out its Wellness program, where the Company’s products are bundled with health screening test and a health camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test reports are completed and delivered to its customers during the consultation section in person. The Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final day of the health camp . For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $ 7,543 0 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) Disaggregated information of revenues by products and services are as follows: SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES 2021 2020 For the years ended December 31, 2021 2020 Survivor Select $ 83,904 $ 149,897 Energized Mineral Concentrate 52,047 81,481 Ionized Cal-Mag 39,527 908,964 Omega Blend 222,718 495,567 BetaMaxx 208,043 156,550 Vege Fruit Fiber 65,757 1,755 Iron 28,114 133,389 Young Formula 52,425 653,631 Organic Youth Care Cleansing Bar 5,137 43,127 Mitogize 183,800 162,801 No. 1 MED 15,331 46,713 Energetique 25,574 253,396 Trim+ 27,042 365,350 Total revenues – products 1,009,419 3,452,621 Health and Wellness services 7,543 - Total revenues $ 1,016,962 $ 3,452,621 Cost of revenue Cost of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue amounted to $ 297,333 36,241 775,855 . Shipping and handling Shipping and handling charges amounted to $ 11,054 9,315 Advertising costs Advertising costs amounted to $ 20,218 14,339 Commission expenses Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $ 316,267 830,659 Defined contribution plan The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan . Total expenses for the plans were $ 99,488 75,802 The related contribution plans include: - Social Security Organization (“SOSCO”) – 1.75 4,000 - Employees Provident Fund (“EPF”) – 12 - Employment Insurance System (“EIS”) – 0.2 4,000 - Human Resource Development Fund (“HRDF”) – 1 Income taxes The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date. Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities. An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% 395 0 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities. Comprehensive income (loss) Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies. Non-controlling interest Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals Earnings (loss) per share The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS . For the years ended December 31, 2021 and 2020, there were no Foreign currencies translation and transaction Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statements of operations and comprehensive income (loss). The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “ Translation of Financial Statement” Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods: SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES As of December 31, 2021 2020 Period-end MYR : US$1 exchange rate 4.18 4.02 Period-end HKD : US$1 exchange rate 7.80 7.75 For the years ended December 31, 2021 2020 Period-average MYR : US$1 exchange rate 4.14 4.20 Period-average HKD : US$1 exchange rate 7.77 7.76 Related parties Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence. Fair value of financial instruments The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company. The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow: ● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. ● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) Leases The Company adopts ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company’s leases include one or more options to renew, which is typically at the Company’s sole discretion. The Company regularly evaluates the renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications result in re-measurement of the right of use (“ROU”) assets and lease liabilities. Operating ROU assets and lease liabilities are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term. Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term. The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows. Recent accounting pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow: In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements. In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contra

VARIABLE INTEREST ENTITY (_VIE_

VARIABLE INTEREST ENTITY (“VIE”)	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
VARIABLE INTEREST ENTITY (“VIE”)	3. VARIABLE INTEREST ENTITY (“VIE”) SEA is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided majority of ASL’s purchases. Its equity at risk was insufficient to finance its activities and 100 a. The power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and b. The obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE . Accordingly, the accounts of SEA is consolidated in the accompanying financial statements. The carrying amount of the VIE’s assets and liabilities were as follows: SCHEDULE OF VARIABLE INTEREST ENTITY As of December 31, 2021 2020 Current assets $ 18,850 $ 48,717 Current liabilities (51,272 ) (53,573 ) Net deficit $ (32,422 ) $ (4,856 ) As of December 31, 2021 2020 Current assets: Cash $ 17,493 $ 37,387 Prepaid taxes 1,357 11,330 Total current assets $ 18,850 $ 48,717 Current liabilities: Accounts payable – intercompany $ 49,724 $ 51,669 Other payables and accrued liabilities 1,548 1,904 Total current liabilities $ 51,272 $ 53,573 Net deficit $ (32,422 ) $ (4,856 ) The summarized operating results of the VIE’s are as follows: For the years ended December 31, 2021 2020 Operating revenues $ - $ 346,907 Gross profit $ - $ 4,442 Loss from operations $ (21,966 ) $ (10,752 ) Net loss $ (27,966 ) $ (24,014 ) AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares)

BUSINESS COMBINATION

BUSINESS COMBINATION	12 Months Ended
	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
BUSINESS COMBINATION	4. BUSINESS COMBINATION On May 8, 2020, the Company entered into a Share Exchange Agreement (“SPA”) with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 no 99.99 1,804,046 656,495 176,547 0.0001 0.0469 1,147,551 6.50 176,547 The Company’s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020 as ASL was under the common control of Mr. How. The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL. SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED Carry Value ASSETS Current assets Cash $ 1,206,493 Other receivables 33,210 Other receivables - related parties 219,121 Inventories 616,880 Prepaid taxes 1,206,821 Prepayments and other assets 318,267 Total current assets 3,600,792 Other assets Property and equipment, net 325,648 Intangible assets, net 6,686 Deferred taxes asset, net 172,250 Total other assets 504,584 Total assets $ 4,105,376 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities Accounts payable - related party $ 491,628 Customer deposits 1,600,606 Other payables and accrued liabilities 209,096 Total current liabilities 2,301,330 Total liabilities $ 2,301,330 Total net assets acquired $ 1,804,046 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 4. BUSINESS COMBINATION (CONT’D) The following unaudited pro forma combined results of operations presents the Company’s financial results as if the acquisition of ASL had been completed on January 1, 2020. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2020. Future results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other factors. SCHEDULE OF PRO FORMA BUSINESS COMBINATION For the year ended December 31, 2020 Revenue $ 4,693,873 Cost of revenue (875,708 ) Gross profit 3,818,165 Total operating expenses (3,839,184 ) Loss from operations (21,019 ) Other income (expense), net 267,633 Income before income taxes 246,614 Provision for income taxes (212,414 ) Net income $ 34,200 Net income per common share - basic and diluted $ 0.00 Weighted average number of common shares outstanding - basic and diluted 376,452,047

CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS	12 Months Ended
	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
CASH AND CASH EQUIVALENTS	5. CASH AND CASH EQUIVALENTS As of December 31, 2021 and 2020 the Company had $ 2,597,848 3,517,600 554,864 1,112,147 $ 1,975,347 and $ 2,391,182 , respectively, of time deposits placed with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time deposits ranges between 1.10 1.25

ACCOUNTS RECEIVABLE

ACCOUNTS RECEIVABLE	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
ACCOUNTS RECEIVABLE	6. ACCOUNTS RECEIVABLE SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY As of December 31, 2021 2020 Accounts receivable $ - $ 172,757 Allowance for doubtful accounts - - Total $ - $ 172,757 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares)

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
INVENTORIES	7. INVENTORIES Inventories consist of the following: SCHEDULE OF INVENTORIES As of December 31, 2021 2020 Finished goods $ 375,535 $ 589,814 For the years ended December 31, 2021 and 2020, the Company recognized $ 36,241 0

PREPAYMENTS AND DEPOSITS

PREPAYMENTS AND DEPOSITS	12 Months Ended
	Dec. 31, 2021
Prepayments And Deposits
PREPAYMENTS AND DEPOSITS	8. PREPAYMENTS AND DEPOSITS SCHEDULE OF PREPAID EXPENSES AND DEPOSITS As of December 31, 2021 2020 Receivables from sales distributors $ 115,379 $ 35,302 Deposits to suppliers 301,233 261,068 Subtotal 416,612 296,370 Less: Provision for doubtful accounts (121,095 ) - Total $ 295,517 $ 296,370 Movements of allowance for doubtful accounts are as follows: SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS For the years ended December 31, 2021 2020 Beginning balance $ - $ - Addition 121,514 - Write off - - Exchange rate effect (419 ) - Ending balance $ 121,095 $ -

PROPERTY AND EQUIPMENT, NET

PROPERTY AND EQUIPMENT, NET	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET	9. PROPERTY AND EQUIPMENT, NET Property and equipment, net consist of the following: SCHEDULE OF PROPERTY AND EQUIPMENT, NET 2021 2020 As of December 31, 2021 2020 Computer and office equipment $ 82,298 $ 81,437 Furniture & fixtures 122,185 126,966 Leasehold improvements 202,570 210,496 Vehicle 98,702 102,564 Subtotal 505,755 521,463 Less: accumulated depreciation (289,956 ) (223,154 ) Total $ 215,799 $ 298,309 Depreciation expense for the years ended December 31, 2021 and 2020 amounted to $ 75,797 55,407 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares)

INTANGIBLE ASSETS, NET

INTANGIBLE ASSETS, NET	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS, NET	10. INTANGIBLE ASSETS, NET Intangible assets, net, consist of the following: SCHEDULE OF INTANGIBLE ASSETS, NET 2021 2020 As of December 31, 2021 2020 Computer software $ 34,453 $ 35,801 Less: accumulated amortization (30,793 ) (29,975 ) Total $ 3,660 $ 5,826 Amortization expense for the years ended December 31, 2021 and 2020 amounted to $ 1,961 1,505

INVESTMENT IN MARKETABLE SECURI

INVESTMENT IN MARKETABLE SECURITIES	12 Months Ended
	Dec. 31, 2021
Investment In Marketable Securities
INVESTMENT IN MARKETABLE SECURITIES	11. INVESTMENT IN MARKETABLE SECURITIES (i) On May 17, 2018, the Company purchased 83,333 500,000 6 (ii) On July 30, 2018, the Company disposed 20 125 6.2613 (iii) On October 16, 2018, the Company purchased 33,333 1,000 0.03 (iv) On November 3, 2020, the Company received dividend of 6,667 76,671 11.50 (v) On December 9, 2020, the Company received dividend of 16,663 83,315 5 (vi) On September 27, 2021, the Company received dividend of 11,665 18,874 1.62 SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES 2021 2020 As of December 31, 2021 2020 Cost of investment $ 577,035 $ 66,484 Dividend income from Greenpro Capital Corp. 18,939 160,062 Unrealized holding (loss) gain (505,231 ) 350,137 Exchange rate effect (1,742 ) 352 Investment in marketable securities $ 89,001 $ 577,035 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares)

INVESTMENT IN NON-MARKETABLE SE

INVESTMENT IN NON-MARKETABLE SECURITIES	12 Months Ended
	Dec. 31, 2021
Investment In Non-marketable Securities
INVESTMENT IN NON-MARKETABLE SECURITIES	12. INVESTMENT IN NON-MARKETABLE SECURITIES The Company invested in Unreserved Sdn Bhd with the investment amount of $ 863,592 3,500,000 20 20.0 17.86 Unreserved Sdn Bhd was incorporated in Malaysia with 2,500,000 On March 3, 2020, the Company agreed to sell the 17.86 730,637 70,173 660,464 On April 3, 2019, the Company purchased a 5 15,000,000 1,500 0.0001 SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES As of December 31, Unreserved Sdn Bhd 2021 2020 Investment in non-marketable securities $ - $ 730,637 Less: Sale of investment in non-marketable securities - (730,637 ) Investment in non-marketable securities - - Phoenix Plus Corporation Cost of investment 1,500 1,500 Total investment in non-marketable securities $ 1,500 $ 1,500

OTHER PAYABLES AND ACCRUED LIAB

OTHER PAYABLES AND ACCRUED LIABILITIES	12 Months Ended
	Dec. 31, 2021
Other Liabilities Disclosure [Abstract]
OTHER PAYABLES AND ACCRUED LIABILITIES	13. OTHER PAYABLES AND ACCRUED LIABILITIES SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES 2021 2020 As of December 31, 2021 2020 Professional fees $ 436,541 $ 297,636 Promotion expenses 36,024 37,433 Payroll 22,669 23,976 Commission 219,721 224,711 Others 143,400 63,921 Total $ 858,355 $ 647,677 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares)

RELATED PARTY BALANCES AND TRAN

RELATED PARTY BALANCES AND TRANSACTIONS	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY BALANCES AND TRANSACTIONS	14. RELATED PARTY BALANCES AND TRANSACTIONS Related party balances Amount due from related parties SCHEDULE OF RELATED PARTIES Name of Related As of December 31, Party Relationship Nature 2021 2020 Agape ATP (Asia) Limited (“AATP Asia”) Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia Expenses paid for AATP Asia $ 2,214 $ 2,227 Hostastay Sdn. Bhd. “Hostastay” Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Sublease rent due from Hostastay 4,790 996 TH3 Technology Sdn Bhd “TH3 Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology Expenses paid for TH3 Technology - 12 Total $ 7,004 $ 3,235 Amount due to a Related Party Name of Related As of December 31, Party Relationship Nature 2021 2020 Agape Superior Living Pty Ltd Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL ATP Label Printing Fees $ - $ 455 Total $ - $ 455 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 14. RELATED PARTY BALANCES AND TRANSACTIONS (CONT’D) Related party transactions Revenue Name of Related For the years ended December 31, Party Relationship Nature 2021 2020 Agape Superior Living Pty Ltd (“ASLPL”) Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Sales of products $ - $ 18,060 Vettons Sdn Bhd* Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021 Sales of products made through its platform 6,625 - Total $ 6,625 $ 18,060 * During the year ended December 31, 2021, the Company had sales of $ 6,625 Purchase For the years ended December 31, Name of Related Party Relationship Nature 2021 2020 DSY Wellness & Longevity Center Sdn Bhd Dato’ Sri Yap Foo Ching Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd Purchase $ 718 $ - Total $ 718 $ - Commission expense For the years ended December 31, Name of Related Party Relationship Nature 2021 2020 Mr. How Kok Choong Mr. How Kok Choong, the CEO and director of the Company Commission expense $ 12,758 $ 10,740 Total $ 12,758 $ 10,740 Other income Name of Related Party For the years ended December 31, Relationship Nature 2021 2020 Hostastay Sdn. Bhd. Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Sublease rental income due from Hostastay $ 4,345 $ 2,881 Total $ 4,345 $ 2,881 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares)

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
STOCKHOLDERS’ EQUITY	15. STOCKHOLDERS’ EQUITY Preferred stock As of December 31, 2021 and 2020, there were 200,000,000 none Common stock As of December 31, 2021 and 2020, there were 1,000,000,000 290,460,047 376,452,047 In May 2020, the Company issued 162,694 In June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased by $ 90,043 13,853 13,853 In December 2021, there were share forfeiture agreements (the “ Share Forfeiture Agreements Forfeiting Shareholders 41,750,000 shares of common stock of the Company, and (ii) the Forfeiting Shareholders had agreed to forfeiture, in aggregate, 44,242,000 shares of common stock of the Company. Included in (ii) is 11,242,000 shares forfeited from HKC Holdings Sdn. Bhd, a company in which Mr. How Kok Choong, 85,992,000 shares of common stock. There were no

NON-CONTROLLING INTEREST

NON-CONTROLLING INTEREST	12 Months Ended
	Dec. 31, 2021
Noncontrolling Interest [Abstract]
NON-CONTROLLING INTEREST	16. NON-CONTROLLING INTEREST The Company’s non-controlling interest consists of the following: SCHEDULE OF NON CONTROLLING INTEREST 2021 2020 As of December 31, 2021 2020 DSY Wellness: Paid-in capital $ 97 $ - Accumulated deficit (436 ) - Accumulated other comprehensive income 3 - Non Controlling interest Gross (336 ) - ASL - - Total $ (336 ) $ - AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares)

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	17. INCOME TAXES The United States and foreign components of (loss) income before income taxes were comprised of the following: SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX For the years ended December 31, 2021 2020 Tax jurisdictions from: Local – United States $ (706,659 ) $ (735,159 ) Foreign – Malaysia (1,064,314 ) 1,070,806 Foreign – Hong Kong (616,640 ) 180,700 Foreign (Loss) income before income tax $ (2,387,613 ) $ 516,347 The (provision for) benefit of income taxes consisted of the following: SCHEDULE OF PROVISION FOR INCOME TAX For the years ended December 31, 2021 2020 Current: - Local $ (22,205 ) $ - - Foreign (104,735 ) 16,748 Deferred: - Local - - - Foreign (10,127 ) (178,329 ) Provision for income taxes $ (137,067 ) $ (161,581 ) The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows: United States of America Agape ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America with a corporate tax rate of 21 35 In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax, which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are applied For the years ended December 31, 2021 and 2020, the Company’s foreign subsidiaries did not generate any income that are subject to Subpart F tax and GILTI tax. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 17. INCOME TAXES (CONT’D) For the year ended December 31, 2021, the Company re-visited its fiscal 2020 U.S. income taxes and determined its stock dividend from Greenpro Capital Corp as a result of its Spin-off of DSwiss Inc.’s shares in 2020 were subject to Subpart F and GILTI taxes. As a result, the Company incurred additional income taxes expenses of $ 22,205 395 312,608 65,648 0 As of December 31, 2021 and 2020, the operations in the United States of America incurred approximately $ 729,000 0 153,000 0 Malaysia Changes to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies incorporated in Labuan to satisfy the “substantial activity requirements” to qualify for the preferential tax rate of 3 24 Agape Superior Living Sdn Bhd, Agape S.E.A Sdn Bhd and Wellness ATP International Holdings Sdn Bhd. are governed by the income taxes laws of Malaysia and the income taxes provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia, enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income taxes rate while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17 As of December 31, 2021 and 2020, the operations in the Malaysia incurred approximately $ 946,000 and $ 261,000 , respectively, of cumulative net operating losses (“NOL”) which can be carried forward to offset future taxable income. Approximately $ 685,000 and $ 261,000 of the net operating loss carry forwards will expire in 2028 and 2027, respectively, if unutilized. The deferred tax valuation allowance as of December 31, 2021 and 2020 were approximately $ 217,000 and $ 0 , respectively. Hong Kong Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 17. INCOME TAXES (CONT’D) The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below: SCHEDULE OF EFFECTIVE INCOME TAX RATE For the years ended December 31, 2021 2020 U.S. statutory rate 21.0 % 21.0 % Valuation allowance (17.0 )% (4.0 )% Differential tax rate in Malaysia 3.0 % 3.0 % Permanent difference (12.7 )%(1) 11.3 %(2) Effective tax rate (5.7 )% 31.3 % (1) The amount comprised: (1) The amount comprised: 6.2 6.7 - 6.2 - 6.7 (2) The amount comprised: (2) The amount comprised: 10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; 0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and 1.3 - 10.2 - 0.2 - 1.3 The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of: SCHEDULE OF DEFERRED TAX ASSETS As of December 31, 2021 2020 Deferred tax assets: Net operating loss carry forwards in U.S. $ 153,061 $ - Net operating loss carry forwards in Malaysia 227,106 62,678 Net operating loss carry forwards Less: valuation allowance (380,167 ) - Deferred tax liabilities: Depreciation (15,574 ) (68,421 ) Deferred tax liabilities, net $ (15,574 ) $ (5,743 ) Uncertain tax positions The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions . As of December 31, 2021 and 2020, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the years ended December 31, 2020 and 2020. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares)

CONCENTRATIONS OF RISKS

CONCENTRATIONS OF RISKS	12 Months Ended
	Dec. 31, 2021
Risks and Uncertainties [Abstract]
CONCENTRATIONS OF RISKS	18. CONCENTRATIONS OF RISKS (a) Major customers For the years ended December 31, 2021 and 2020, no customer accounted for 10 There are no accounts receivable balance as of December 31, 2021. As of December 31, 2020, receivables from a third-party e-commerce company accounted for approximately 100.0 (b) Major vendors For the year ended December 31, 2021, two vendors accounted for approximately 47.3 % and 45.2 % of the Company’s total purchases, respectively. For the year ended December 31, 2020, two vendors accounted for approximately 74.1 % and 25.9 % of the Company’s total purchases. In November and December 2020, the Company received dividend of 23,330 shares of common stock of DSwiss, Inc., represents approximately 0.01 % ownership that the Company accounted for as investment in marketable securities (See Note 11). DSwiss, Inc.’s wholly owned subsidiary is the vendor that accounted for the Company’s total purchases of approximately 47.3 % and 74.1 % for the years ended December 31, 2021 and 2020, respectively. As of December 31, 2021, one vendor accounted for 100 (c) Commission Expenses to Sales Distributors and Stockists For the year ended December 31, 2021, one sales distributor accounted for 17.9 For the year ended December 31, 2020, no sales distributor accounted for 10.0 (d) Credit risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of December 31, 2021 and 2020, $ 554,864 1,112,147 295,761 563,788 Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically, the Company did not have any bad debt on its account receivable. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 18. CONCENTRATIONS OF RISKS (CONT’D) (e) Exchange rate risk The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	19. COMMITMENTS AND CONTINGENCIES Lease commitments On April 1, 2020, the Company adopted ASC 842 for ASL’s office space lease and sales and training center as the lease commencement date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $ 490,000 5.5 On May 31, 2021, the Company entered into two separate two-year leases extension with the modified lease expiring May 31, 2023 August 31, 2023 3,250 5.5 As of December 31, 2021, the weighted remaining term of the lease is approximately 1.64 The five-year maturity of the Company’s operating lease liabilities is as follow: SCHEDULE OF LEASE COMMITMENTS Twelve Months Ending December 31, Operating lease liabilities 2022 $ 166,426 2023 84,915 Thereafter - Total lease payments 251,341 Less: interest (10,763 ) Present value of lease liabilities $ 240,578 Rent expense for the years ended December 31, 2021 and 2020 was $ 179,562 156,716 Contingencies Legal From time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued, as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 19. COMMITMENTS AND CONTINGENCIES (CONT’D) COVID-19 Since the declaration of the COVID-19 a pandemic on March 11, 2020, by the World Health Organization or WHO, Malaysia has been put through various stages of lockdowns such as (1) full movement control orders (“MCO”), under which, quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia were made mandatory, (2) MCO were eased to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia and (3) CMCO were further relaxed to Recovery Movement Control Order (“RMCO”). On January 12, 2021, due to a resurgence of COVID-19 cases, the Malaysian government declared a state of emergency nationwide to combat COVID-19. Intermittent lockdowns were imposed in various states and districts in the country. February 2021 marked a significant month for Malaysia as all frontline staff of the country, which comprised those in healthcare, police, the Volunteers Department of Malaysia, the Fire and Rescue Department of Malaysia and civil defense sectors were vaccinated. On February 16, 2021, Prime Minister, Tan Sri Muhyiddin Yassin announced that a National COVID-19 Immunisation Plan will be implemented for one year after February 2021, which 80% of the Malaysia population will be vaccinated to achieve herd immunization. On March 5, 2021, lockdowns in most part of the country was eased to a CMCO, nevertheless, COVID-19 cases in the country continue to rise. On May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced Movement Control Order (“EMCO”) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021, interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country’s population have been fully vaccinated, with a further 46.0% having received booster shot . Substantially all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to, the following: ● temporary closure of offices, travel restrictions, financial impact of the Company’s customers or suspension supplies may be negatively affected, and could continue to negatively affect the demand for the Company’s product; ● the Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely affect its financial condition and operating results; and ● any disruption of the Company’s supply chain, logistics providers or customers could adversely impact its business and results of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery to its customers, which may also lead to loss of its customers. Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot be reasonably estimated at this time. There is no guarantee that the Company’s total revenues will grow or remain at the similar level year over year in 2021 and 2022.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	20. SUBSEQUENT EVENTS Forfeiture of Common Stock A share forfeiture agreement (the “Share Forfeiture Agreement”) dated January 20, 2022, between the Company and Mr. How Kok Choong, the CEO and director of the Company , pursuant to which Mr. How Kok Choong agreed to forfeit 215,008,035

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information pursuant to the rules and regulations of the Securities Exchange Commission (“SEC”). The consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.
Principles of consolidation	Principles of consolidation Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors. A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE.
Use of estimates	Use of estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.
Cash and cash equivalents	Cash and cash equivalents Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.
Accounts receivable	Accounts receivable Accounts receivable are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, no
Inventories	Inventories Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method. Management reviews inventory on hand for estimated obsolescence or unmarketable items, as compared to future demand requirements and the shelf life of the various products. Based on the review, the Company records inventory write-downs, when necessary, when costs exceed expected net realizable value. For the years ended December 31, 2021, and 2020, the company recorded $ 36,241 0
Prepaid taxes	Prepaid taxes Prepaid taxes include prepaid income taxes that will either be refunded or utilized to offset future income tax .
Prepayments and deposits	Prepayments and deposits Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of December 31, 2021 and 2020, there was $ 121,514 0
Property and equipment, net	Property and equipment, net Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows: SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT Useful Life Computer and office equipment 5 7 Furniture & fixtures 6 7 Leasehold improvements Lease Term Vehicle 5 The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.
Intangible assets, net	Intangible assets, net Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows: SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET Classification Useful Life Computer software 5
Impairment for long-lived assets	Impairment for long-lived assets Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of December 31, 2021 and 2020, no
Deferred offering costs	Deferred offering costs Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.
Investment in marketable equity securities	Investment in marketable equity securities The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities .
Investment in non-marketable equity securities	Investment in non-marketable equity securities The Company follows the provisions of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.
Customer deposits	Customer deposits Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.
Revenue recognition	Revenue recognition The Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606). The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products. The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) Sales of Health and Wellness products - Performance obligations satisfied at a point in time The Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns . The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the years ended December 31, 2021 and 2020, the Company recognized $ 15,209 170,431 As of December 31, 2021, the Company had contracts for the sales of health and wellness products amounting to $ 183,816 Sales of Health and Wellness services - Performance obligations satisfied at a point in time The Company carries out its Wellness program, where the Company’s products are bundled with health screening test and a health camp program. The health screening test and the health camp programs are considered as separate performance obligations. The promises to deliver the health screening test report and the attendance at the health camp are separately identifiable, which are evidenced by the fact that the Company provides separate services of delivering the health screening test report and allowing admission of the customers to attend the health camp. The Company derives its revenues from sales contracts with its customers with revenues being recognized when the test reports are completed and delivered to its customers during the consultation section in person. The Company also separately derives its revenues from sales contracts with its customers with revenues being recognized when the health camp program was completed in the final day of the health camp . For the years ended December 31, 2021 and 2020, revenues from health and wellness services are $ 7,543 0 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) Disaggregated information of revenues by products and services are as follows: SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES 2021 2020 For the years ended December 31, 2021 2020 Survivor Select $ 83,904 $ 149,897 Energized Mineral Concentrate 52,047 81,481 Ionized Cal-Mag 39,527 908,964 Omega Blend 222,718 495,567 BetaMaxx 208,043 156,550 Vege Fruit Fiber 65,757 1,755 Iron 28,114 133,389 Young Formula 52,425 653,631 Organic Youth Care Cleansing Bar 5,137 43,127 Mitogize 183,800 162,801 No. 1 MED 15,331 46,713 Energetique 25,574 253,396 Trim+ 27,042 365,350 Total revenues – products 1,009,419 3,452,621 Health and Wellness services 7,543 - Total revenues $ 1,016,962 $ 3,452,621
Cost of revenue	Cost of revenue Cost of revenue includes freight-in, the purchase cost of manufactured goods for sale to customers, and inventory write-downs. Cost of revenue amounted to $ 297,333 36,241 775,855 .
Shipping and handling	Shipping and handling Shipping and handling charges amounted to $ 11,054 9,315
Advertising costs	Advertising costs Advertising costs amounted to $ 20,218 14,339
Commission expenses	Commission expenses Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $ 316,267 830,659
Defined contribution plan	Defined contribution plan The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan . Total expenses for the plans were $ 99,488 75,802 The related contribution plans include: - Social Security Organization (“SOSCO”) – 1.75 4,000 - Employees Provident Fund (“EPF”) – 12 - Employment Insurance System (“EIS”) – 0.2 4,000 - Human Resource Development Fund (“HRDF”) – 1
Income taxes	Income taxes The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date. Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities. An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% 395 0 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.
Comprehensive income (loss)	Comprehensive income (loss) Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.
Non-controlling interest	Non-controlling interest Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals
Earnings (loss) per share	Earnings (loss) per share The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS . For the years ended December 31, 2021 and 2020, there were no
Foreign currencies translation and transaction	Foreign currencies translation and transaction Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the consolidated statements of operations and comprehensive income (loss). The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “ Translation of Financial Statement” Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods: SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES As of December 31, 2021 2020 Period-end MYR : US$1 exchange rate 4.18 4.02 Period-end HKD : US$1 exchange rate 7.80 7.75 For the years ended December 31, 2021 2020 Period-average MYR : US$1 exchange rate 4.14 4.20 Period-average HKD : US$1 exchange rate 7.77 7.76
Related parties	Related parties Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.
Fair value of financial instruments	Fair value of financial instruments The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company. The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow: ● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. ● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. ● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.
Leases	Leases The Company adopts ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopts the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. Some of the Company’s leases include one or more options to renew, which is typically at the Company’s sole discretion. The Company regularly evaluates the renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. New lease modifications result in re-measurement of the right of use (“ROU”) assets and lease liabilities. Operating ROU assets and lease liabilities are recognized at the commencement date, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term. Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term. The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.
Recent accounting pronouncements	Recent accounting pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow: In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT’D) In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its consolidated financial statements. In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements. In October 2020, the FASB issued ASU 2020-08, “Codification Improvements to Subtopic 310-20, Receivables—Nonrefundable Fees and Other Costs”. The amendments in this Update represent changes to clarify the Codification. The amendments make the Codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. ASU 2020-08 is effective for the Company for annual and interim reporting periods beginning January 1, 2021. Early application is not permitted. All entities should apply the amendments in this Update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. These amendments do not change the effective dates for Update 2017-08. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements. In October 2020, the FASB issued ASU 2020-10, “Codification Improvements”. The amendments in this Update represent changes to clarify the Codification or correct unintended application of guidance that are not expected to have a significant effect on current accounting practice or create a significant administrative cost to most entities. The amendments in this Update affect a wide variety of Topics in the Codification and apply to all reporting entities within the scope of the affected accounting guidance. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public business entities. Early application is permitted. The amendments in this Update should be applied retrospectively. The adoption of this standard on January 1, 2021 did not have a material impact on its consolidated financial statements.

ORGANIZATION AND BUSINESS BAC_2

ORGANIZATION AND BUSINESS BACKGROUND (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
SCHEDULE OF SUBSIDIARIES AND ASSOCIATES	Details of the Company’s subsidiaries: SCHEDULE OF SUBSIDIARIES AND ASSOCIATES Subsidiary company name Place and date of incorporation Particulars of issued capital Principal activities Proportional of ownership interest and voting power held 1. Agape ATP Corporation Labuan, 100 shares of ordinary share of US$1 each Investment holding 100 % 2. Agape ATP International Holding Limited Hong Kong, 1,000,000 shares of ordinary share of HK$1 each Wholesaling of health and wellness products; and health solution advisory services 100 % 3. Agape Superior Living Sdn. Bhd. Malaysia, 9,590,598 shares of ordinary share of RM1 each Health and wellness products and health solution advisory services via network marketing 99.99 % 4. Agape S.E.A. Sdn. Bhd. Malaysia, 2 shares of ordinary share of RM1 each VIE of Agape Superior Living Sdn. Bhd. VIE 5. Wellness ATP International Holdings Sdn, Bhd Malaysia, 100 shares of ordinary share of RM1 each The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns 100 % 6. DSY Wellness International Sdn Bhd. Malaysia, 1,000 shares of ordinary share of RM1 each Provision of complementary health therapies 60 %

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT	Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows: SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT Useful Life Computer and office equipment 5 7 Furniture & fixtures 6 7 Leasehold improvements Lease Term Vehicle 5
SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET	Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows: SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET Classification Useful Life Computer software 5
SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES	Disaggregated information of revenues by products and services are as follows: SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES 2021 2020 For the years ended December 31, 2021 2020 Survivor Select $ 83,904 $ 149,897 Energized Mineral Concentrate 52,047 81,481 Ionized Cal-Mag 39,527 908,964 Omega Blend 222,718 495,567 BetaMaxx 208,043 156,550 Vege Fruit Fiber 65,757 1,755 Iron 28,114 133,389 Young Formula 52,425 653,631 Organic Youth Care Cleansing Bar 5,137 43,127 Mitogize 183,800 162,801 No. 1 MED 15,331 46,713 Energetique 25,574 253,396 Trim+ 27,042 365,350 Total revenues – products 1,009,419 3,452,621 Health and Wellness services 7,543 - Total revenues $ 1,016,962 $ 3,452,621
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES	Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods: SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES As of December 31, 2021 2020 Period-end MYR : US$1 exchange rate 4.18 4.02 Period-end HKD : US$1 exchange rate 7.80 7.75 For the years ended December 31, 2021 2020 Period-average MYR : US$1 exchange rate 4.14 4.20 Period-average HKD : US$1 exchange rate 7.77 7.76

VARIABLE INTEREST ENTITY (_VI_2

VARIABLE INTEREST ENTITY (“VIE”) (Tables)	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SCHEDULE OF VARIABLE INTEREST ENTITY	The carrying amount of the VIE’s assets and liabilities were as follows: SCHEDULE OF VARIABLE INTEREST ENTITY As of December 31, 2021 2020 Current assets $ 18,850 $ 48,717 Current liabilities (51,272 ) (53,573 ) Net deficit $ (32,422 ) $ (4,856 ) As of December 31, 2021 2020 Current assets: Cash $ 17,493 $ 37,387 Prepaid taxes 1,357 11,330 Total current assets $ 18,850 $ 48,717 Current liabilities: Accounts payable – intercompany $ 49,724 $ 51,669 Other payables and accrued liabilities 1,548 1,904 Total current liabilities $ 51,272 $ 53,573 Net deficit $ (32,422 ) $ (4,856 ) The summarized operating results of the VIE’s are as follows: For the years ended December 31, 2021 2020 Operating revenues $ - $ 346,907 Gross profit $ - $ 4,442 Loss from operations $ (21,966 ) $ (10,752 ) Net loss $ (27,966 ) $ (24,014 )

BUSINESS COMBINATION (Tables)

BUSINESS COMBINATION (Tables)	12 Months Ended
	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED	The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL. SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED Carry Value ASSETS Current assets Cash $ 1,206,493 Other receivables 33,210 Other receivables - related parties 219,121 Inventories 616,880 Prepaid taxes 1,206,821 Prepayments and other assets 318,267 Total current assets 3,600,792 Other assets Property and equipment, net 325,648 Intangible assets, net 6,686 Deferred taxes asset, net 172,250 Total other assets 504,584 Total assets $ 4,105,376 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities Accounts payable - related party $ 491,628 Customer deposits 1,600,606 Other payables and accrued liabilities 209,096 Total current liabilities 2,301,330 Total liabilities $ 2,301,330 Total net assets acquired $ 1,804,046
SCHEDULE OF PRO FORMA BUSINESS COMBINATION	SCHEDULE OF PRO FORMA BUSINESS COMBINATION For the year ended December 31, 2020 Revenue $ 4,693,873 Cost of revenue (875,708 ) Gross profit 3,818,165 Total operating expenses (3,839,184 ) Loss from operations (21,019 ) Other income (expense), net 267,633 Income before income taxes 246,614 Provision for income taxes (212,414 ) Net income $ 34,200 Net income per common share - basic and diluted $ 0.00 Weighted average number of common shares outstanding - basic and diluted 376,452,047

ACCOUNTS RECEIVABLE (Tables)

ACCOUNTS RECEIVABLE (Tables)	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY	SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY As of December 31, 2021 2020 Accounts receivable $ - $ 172,757 Allowance for doubtful accounts - - Total $ - $ 172,757

INVENTORIES (Tables)

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
SCHEDULE OF INVENTORIES	Inventories consist of the following: SCHEDULE OF INVENTORIES As of December 31, 2021 2020 Finished goods $ 375,535 $ 589,814

PREPAYMENTS AND DEPOSITS (Table

PREPAYMENTS AND DEPOSITS (Tables)	12 Months Ended
	Dec. 31, 2021
Prepayments And Deposits
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS	SCHEDULE OF PREPAID EXPENSES AND DEPOSITS As of December 31, 2021 2020 Receivables from sales distributors $ 115,379 $ 35,302 Deposits to suppliers 301,233 261,068 Subtotal 416,612 296,370 Less: Provision for doubtful accounts (121,095 ) - Total $ 295,517 $ 296,370
SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS	Movements of allowance for doubtful accounts are as follows: SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS For the years ended December 31, 2021 2020 Beginning balance $ - $ - Addition 121,514 - Write off - - Exchange rate effect (419 ) - Ending balance $ 121,095 $ -

PROPERTY AND EQUIPMENT, NET (Ta

PROPERTY AND EQUIPMENT, NET (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT, NET	Property and equipment, net consist of the following: SCHEDULE OF PROPERTY AND EQUIPMENT, NET 2021 2020 As of December 31, 2021 2020 Computer and office equipment $ 82,298 $ 81,437 Furniture & fixtures 122,185 126,966 Leasehold improvements 202,570 210,496 Vehicle 98,702 102,564 Subtotal 505,755 521,463 Less: accumulated depreciation (289,956 ) (223,154 ) Total $ 215,799 $ 298,309

INTANGIBLE ASSETS, NET (Tables)

INTANGIBLE ASSETS, NET (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
SCHEDULE OF INTANGIBLE ASSETS, NET	Intangible assets, net, consist of the following: SCHEDULE OF INTANGIBLE ASSETS, NET 2021 2020 As of December 31, 2021 2020 Computer software $ 34,453 $ 35,801 Less: accumulated amortization (30,793 ) (29,975 ) Total $ 3,660 $ 5,826

INVESTMENT IN MARKETABLE SECU_2

INVESTMENT IN MARKETABLE SECURITIES (Tables)	12 Months Ended
	Dec. 31, 2021
Investment In Marketable Securities
SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES	SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES 2021 2020 As of December 31, 2021 2020 Cost of investment $ 577,035 $ 66,484 Dividend income from Greenpro Capital Corp. 18,939 160,062 Unrealized holding (loss) gain (505,231 ) 350,137 Exchange rate effect (1,742 ) 352 Investment in marketable securities $ 89,001 $ 577,035

INVESTMENT IN NON-MARKETABLE _2

INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)	12 Months Ended
	Dec. 31, 2021
Investment In Non-marketable Securities
SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES	SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES As of December 31, Unreserved Sdn Bhd 2021 2020 Investment in non-marketable securities $ - $ 730,637 Less: Sale of investment in non-marketable securities - (730,637 ) Investment in non-marketable securities - - Phoenix Plus Corporation Cost of investment 1,500 1,500 Total investment in non-marketable securities $ 1,500 $ 1,500

OTHER PAYABLES AND ACCRUED LI_2

OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2021
Other Liabilities Disclosure [Abstract]
SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES	SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES 2021 2020 As of December 31, 2021 2020 Professional fees $ 436,541 $ 297,636 Promotion expenses 36,024 37,433 Payroll 22,669 23,976 Commission 219,721 224,711 Others 143,400 63,921 Total $ 858,355 $ 647,677

RELATED PARTY BALANCES AND TR_2

RELATED PARTY BALANCES AND TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
SCHEDULE OF RELATED PARTIES	SCHEDULE OF RELATED PARTIES Name of Related As of December 31, Party Relationship Nature 2021 2020 Agape ATP (Asia) Limited (“AATP Asia”) Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia Expenses paid for AATP Asia $ 2,214 $ 2,227 Hostastay Sdn. Bhd. “Hostastay” Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Sublease rent due from Hostastay 4,790 996 TH3 Technology Sdn Bhd “TH3 Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology Expenses paid for TH3 Technology - 12 Total $ 7,004 $ 3,235 Amount due to a Related Party Name of Related As of December 31, Party Relationship Nature 2021 2020 Agape Superior Living Pty Ltd Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL ATP Label Printing Fees $ - $ 455 Total $ - $ 455 AGAPE ATP CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Currency expressed in United States Dollars (“US$”), except for number of shares) 14. RELATED PARTY BALANCES AND TRANSACTIONS (CONT’D) Related party transactions Revenue Name of Related For the years ended December 31, Party Relationship Nature 2021 2020 Agape Superior Living Pty Ltd (“ASLPL”) Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Sales of products $ - $ 18,060 Vettons Sdn Bhd* Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021 Sales of products made through its platform 6,625 - Total $ 6,625 $ 18,060 * During the year ended December 31, 2021, the Company had sales of $ 6,625 Purchase For the years ended December 31, Name of Related Party Relationship Nature 2021 2020 DSY Wellness & Longevity Center Sdn Bhd Dato’ Sri Yap Foo Ching Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd Purchase $ 718 $ - Total $ 718 $ - Commission expense For the years ended December 31, Name of Related Party Relationship Nature 2021 2020 Mr. How Kok Choong Mr. How Kok Choong, the CEO and director of the Company Commission expense $ 12,758 $ 10,740 Total $ 12,758 $ 10,740 Other income Name of Related Party For the years ended December 31, Relationship Nature 2021 2020 Hostastay Sdn. Bhd. Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay Sublease rental income due from Hostastay $ 4,345 $ 2,881 Total $ 4,345 $ 2,881

NON-CONTROLLING INTEREST (Table

NON-CONTROLLING INTEREST (Tables)	12 Months Ended
	Dec. 31, 2021
Noncontrolling Interest [Abstract]
SCHEDULE OF NON CONTROLLING INTEREST	The Company’s non-controlling interest consists of the following: SCHEDULE OF NON CONTROLLING INTEREST 2021 2020 As of December 31, 2021 2020 DSY Wellness: Paid-in capital $ 97 $ - Accumulated deficit (436 ) - Accumulated other comprehensive income 3 - Non Controlling interest Gross (336 ) - ASL - - Total $ (336 ) $ -

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX	The United States and foreign components of (loss) income before income taxes were comprised of the following: SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX For the years ended December 31, 2021 2020 Tax jurisdictions from: Local – United States $ (706,659 ) $ (735,159 ) Foreign – Malaysia (1,064,314 ) 1,070,806 Foreign – Hong Kong (616,640 ) 180,700 Foreign (Loss) income before income tax $ (2,387,613 ) $ 516,347
SCHEDULE OF PROVISION FOR INCOME TAX	The (provision for) benefit of income taxes consisted of the following: SCHEDULE OF PROVISION FOR INCOME TAX For the years ended December 31, 2021 2020 Current: - Local $ (22,205 ) $ - - Foreign (104,735 ) 16,748 Deferred: - Local - - - Foreign (10,127 ) (178,329 ) Provision for income taxes $ (137,067 ) $ (161,581 )
SCHEDULE OF EFFECTIVE INCOME TAX RATE	The following table reconciles the local (United States) statutory rates to the Company’s effective tax rate for the periods indicated below: SCHEDULE OF EFFECTIVE INCOME TAX RATE For the years ended December 31, 2021 2020 U.S. statutory rate 21.0 % 21.0 % Valuation allowance (17.0 )% (4.0 )% Differential tax rate in Malaysia 3.0 % 3.0 % Permanent difference (12.7 )%(1) 11.3 %(2) Effective tax rate (5.7 )% 31.3 % (1) The amount comprised: (1) The amount comprised: 6.2 6.7 - 6.2 - 6.7 (2) The amount comprised: (2) The amount comprised: 10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; 0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and 1.3 - 10.2 - 0.2 - 1.3
SCHEDULE OF DEFERRED TAX ASSETS	The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of: SCHEDULE OF DEFERRED TAX ASSETS As of December 31, 2021 2020 Deferred tax assets: Net operating loss carry forwards in U.S. $ 153,061 $ - Net operating loss carry forwards in Malaysia 227,106 62,678 Net operating loss carry forwards Less: valuation allowance (380,167 ) - Deferred tax liabilities: Depreciation (15,574 ) (68,421 ) Deferred tax liabilities, net $ (15,574 ) $ (5,743 )

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
SCHEDULE OF LEASE COMMITMENTS	The five-year maturity of the Company’s operating lease liabilities is as follow: SCHEDULE OF LEASE COMMITMENTS Twelve Months Ending December 31, Operating lease liabilities 2022 $ 166,426 2023 84,915 Thereafter - Total lease payments 251,341 Less: interest (10,763 ) Present value of lease liabilities $ 240,578

SCHEDULE OF SUBSIDIARIES AND AS

SCHEDULE OF SUBSIDIARIES AND ASSOCIATES (Details)	12 Months Ended
	Dec. 31, 2021	Nov. 11, 2021	May 08, 2020
Subsidiary Company [Member]
Subsidiary company name	Agape ATP Corporation
Place and date of incorporation	Labuan, March 6, 2017
Particulars of issued capital	100 shares of ordinary share of US$1 each
Principal activities	Investment holding
Proportional of ownership interest and voting power held	100.00%
Subsidiary Company One [Member]
Subsidiary company name	Agape ATP International Holding Limited
Place and date of incorporation	Hong Kong, June 1, 2017
Particulars of issued capital	1,000,000 shares of ordinary share of HK$1 each
Principal activities	Wholesaling of health and wellness products; and health solution advisory services
Proportional of ownership interest and voting power held	100.00%
Subsidiary Company Two [Member]
Subsidiary company name	Agape Superior Living Sdn. Bhd.
Place and date of incorporation	Malaysia, August 8, 2003
Particulars of issued capital	9,590,598 shares of ordinary share of RM1 each
Principal activities	Health and wellness products and health solution advisory services via network marketing
Proportional of ownership interest and voting power held	99.99%		99.99%
Subsidiary Company Three [Member]
Subsidiary company name	Agape S.E.A. Sdn. Bhd.
Place and date of incorporation	Malaysia, March 4, 2004
Particulars of issued capital	2 shares of ordinary share of RM1 each
Principal activities	VIE of Agape Superior Living Sdn. Bhd.
Proportional of ownership interest and voting power held	100.00%
Subsidiary Company Four [Member]
Subsidiary company name	Wellness ATP International Holdings Sdn, Bhd
Place and date of incorporation	Malaysia, September 11, 2020
Particulars of issued capital	100 shares of ordinary share of RM1 each
Principal activities	The promotion of wellness and wellbeing lifestyle of the community by providing services that includes online editorials, programs, events and campaigns
Proportional of ownership interest and voting power held	100.00%
Subsidiary Company Five [Member]
Subsidiary company name	DSY Wellness International Sdn Bhd.
Place and date of incorporation	Malaysia, November 11, 2021
Particulars of issued capital	1,000 shares of ordinary share of RM1 each
Principal activities	Provision of complementary health therapies
Proportional of ownership interest and voting power held	60.00%	60.00%

ORGANIZATION AND BUSINESS BAC_3

ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) - shares	May 08, 2020	Dec. 31, 2021	Nov. 11, 2021
Share Exchange Agreement [Member] | Mr.How Kok Choong [Member]
Ownership interest percentage	99.99%
Stock issued during period acquisitions, shares	9,590,596
Agape ATP International Holding Limited [Member]
Ownership interest percentage		100.00%
Subsidiary Company Two [Member]
Ownership interest percentage	99.99%	99.99%
Subsidiary Company Five [Member]
Ownership interest percentage		60.00%	60.00%

SCHEDULE OF ESTIMATED USEFUL LI

SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)	12 Months Ended
	Dec. 31, 2021
Computer Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life of Property and Equipment	5 years
Computer Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life of Property and Equipment	7 years
Furniture and Fixtures [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life of Property and Equipment	6 years
Furniture and Fixtures [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life of Property and Equipment	7 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Lives of Property and Equipment	Lease Term
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Estimated Useful Life of Property and Equipment	5 years

SCHEDULE OF ESTIMATED USEFUL _2

SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)	12 Months Ended
	Dec. 31, 2021
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives of intangible assets	5 years

SCHEDULE OF DIS-AGGREGATED INFO

SCHEDULE OF DIS-AGGREGATED INFORMATION OF REVENUES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Product Information [Line Items]
Total revenues	$ 1,016,962	$ 3,452,621
Survivor Select [Member]
Product Information [Line Items]
Total revenues	83,904	149,897
Energized Mineral Concentrate [Member]
Product Information [Line Items]
Total revenues	52,047	81,481
Ionized Cal-Mag [Member]
Product Information [Line Items]
Total revenues	39,527	908,964
Omega Blend [Member]
Product Information [Line Items]
Total revenues	222,718	495,567
Beta Maxx [Member]
Product Information [Line Items]
Total revenues	208,043	156,550
Vege Fruit Fiber [Member]
Product Information [Line Items]
Total revenues	65,757	1,755
Iron [Member]
Product Information [Line Items]
Total revenues	28,114	133,389
Young Formula [Member]
Product Information [Line Items]
Total revenues	52,425	653,631
Organic Youth Care Cleansing Bar [Member]
Product Information [Line Items]
Total revenues	5,137	43,127
Mitogize [Member]
Product Information [Line Items]
Total revenues	183,800	162,801
No. 1 MED [Member]
Product Information [Line Items]
Total revenues	15,331	46,713
Energetique [Member]
Product Information [Line Items]
Total revenues	25,574	253,396
Trim Plus [Member]
Product Information [Line Items]
Total revenues	27,042	365,350
Product [Member]
Product Information [Line Items]
Total revenues	1,009,419	3,452,621
Health And Wellness Services [Member]
Product Information [Line Items]
Total revenues	$ 7,543

SCHEDULE OF FOREIGN CURRENCIES

SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Period-end MYR [Member]
Debt Instrument [Line Items]
Foreign Currency Exchange Rate, Translation	4.18	4.02
Period-end HKD [Member]
Debt Instrument [Line Items]
Foreign Currency Exchange Rate, Translation	7.80	7.75
Period-average MYR [Member]
Debt Instrument [Line Items]
Foreign currency exchange rate period average	4.14	4.20
Period-average HKD [Member]
Debt Instrument [Line Items]
Foreign currency exchange rate period average	7.77	7.76

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	12 Months Ended
	Dec. 31, 2021USD ($)shares	Dec. 31, 2021MYR (RM)shares	Dec. 31, 2020USD ($)shares	Dec. 31, 2020MYR (RM)shares
Product Information [Line Items]
Accounts receivable, allowance for credit loss
Inventories write-down	36,241
Allowance for doubtful accounts	121,514		0
Impairment of long-lived assets	0		0
Forfeited coupon income	15,209		170,431
Revenue from sales	1,016,962		3,434,561
Cost of revenue	297,333		775,855
Selling expenses	394,682		376,582
Advertising costs	20,218		14,339
Commission expenses	316,267		830,659
Defined contribution plan expense	$ 99,488		75,802
Income tax examination, likelihood of unfavorable settlement	greater than 50%	greater than 50%
Income tax examination, penalties and interest expense	$ 395		$ 0
Noncontrolling interest, description	Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals	Non-controlling interest consists of 40% of the equity interests of DSY Wellness held by an individual and approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals
Potentially dilutive securities outstanding | shares	0	0	0	0
Social Security Organization [Member]
Product Information [Line Items]
Salary percentage	1.75%	1.75%
Social Security Organization [Member] | MYR Currency [Member]
Product Information [Line Items]
Monthly salary | RM				RM 4,000
Employees Provident Fund [Member]
Product Information [Line Items]
Salary percentage	12.00%	12.00%
Employment Insurance System [Member]
Product Information [Line Items]
Salary percentage	0.20%	0.20%
Employment Insurance System [Member] | MYR Currency [Member]
Product Information [Line Items]
Monthly salary | RM		RM 4,000
Human Resource Development Fund [Member]
Product Information [Line Items]
Salary percentage	1.00%	1.00%
Health and Wellness Products [Member]
Product Information [Line Items]
Revenue from sales	$ 183,816
Health And Wellness Services [Member]
Product Information [Line Items]
Revenue from sales	7,543		$ 0
Shipping and Handling [Member]
Product Information [Line Items]
Selling expenses	$ 11,054		$ 9,315

SCHEDULE OF VARIABLE INTEREST E

SCHEDULE OF VARIABLE INTEREST ENTITY (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Trading Activity, Gains and Losses, Net [Line Items]
Total current assets	$ 3,912,122	$ 5,684,271
Current liabilities	(1,312,841)	(1,038,542)
Net deficit	3,312,972	5,924,834
Cash	2,597,848	3,517,600
Prepaid taxes	636,218	1,104,495
Total current liabilities	1,312,841	1,038,542
Operating revenues	1,016,962	3,434,561
Gross profit	719,629	2,676,766
Loss from operations	(1,858,568)	(158,135)
Net loss	(2,524,244)	354,766
Variable Income Interest Rate [Member]
Trading Activity, Gains and Losses, Net [Line Items]
Total current assets	18,850	48,717
Current liabilities	(51,272)	(53,573)
Net deficit	(32,422)	(4,856)
Cash	17,493	37,387
Prepaid taxes	1,357	11,330
Accounts payable – intercompany	49,724	51,669
Other payables and accrued liabilities	1,548	1,904
Total current liabilities	51,272	53,573
Operating revenues		346,907
Gross profit		4,442
Loss from operations	(21,966)	(10,752)
Net loss	$ (27,966)	$ (24,014)

VARIABLE INTEREST ENTITY (_VI_3

VARIABLE INTEREST ENTITY (“VIE”) (Details Narrative)	Dec. 31, 2021
Subsidiary Company Three [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership interest percentage	100.00%

SUMMARY OF ASSETS ACQUIRED AND

SUMMARY OF ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)	Dec. 31, 2021USD ($)
Business Combination and Asset Acquisition [Abstract]
Cash	$ 1,206,493
Other receivables	33,210
Other receivables - related parties	219,121
Inventories	616,880
Prepaid taxes	1,206,821
Prepayments and other assets	318,267
Total current assets	3,600,792
Property and equipment, net	325,648
Intangible assets, net	6,686
Deferred taxes asset, net	172,250
Total other assets	504,584
Total assets	4,105,376
Accounts payable - related party	491,628
Customer deposits	1,600,606
Other payables and accrued liabilities	209,096
Total current liabilities	2,301,330
Total liabilities	2,301,330
Total net assets acquired	$ 1,804,046

SCHEDULE OF PRO FORMA BUSINESS

SCHEDULE OF PRO FORMA BUSINESS COMBINATION (Details)	12 Months Ended
	Dec. 31, 2020USD ($)$ / sharesshares
Business Combination and Asset Acquisition [Abstract]
Revenue	$ 4,693,873
Cost of revenue	(875,708)
Gross profit	3,818,165
Total operating expenses	(3,839,184)
Loss from operations	(21,019)
Other income (expense), net	267,633
Income before income taxes	246,614
Provision for income taxes	(212,414)
Net income	$ 34,200
Net income per common share - basic and diluted | $ / shares	$ 0
Weighted average number of common shares outstanding - basic and diluted | shares	376,452,047

BUSINESS COMBINATION (Details N

BUSINESS COMBINATION (Details Narrative) - USD ($)	Jul. 02, 2020	May 08, 2020	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Common stock par value				$ 0.0001	$ 0.0001
Mr.How Kok Choong [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Purchased price per shares			$ 6.50
Share Exchange Agreement [Member] | Mr.How Kok Choong [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period acquisitions, shares		9,590,596
Ownership interest percentage		99.99%
Share Exchange Agreement [Member] | Mr.How Kok Choong [Member] | Agape Superior Living Sdn Bhd [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period acquisitions, shares			176,547
Ordinary shares no par value		$ 0
Ownership interest percentage		99.99%
Purchase consideration value	$ 1,804,046
Loan payable			$ 656,495
Common stock par value			$ 0.0001
Percentage of common stock issued and outstanding			0.0469%
Stock issued during period, value, acquisitions			$ 1,147,551
Issuance of common stock shares				176,547

CASH AND CASH EQUIVALENTS (Deta

CASH AND CASH EQUIVALENTS (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Cash and cash equivalents	$ 2,597,848	$ 3,517,600
Cash in bank	554,864	1,112,147
Time deposits	$ 1,975,347	$ 2,391,182
Minimum [Member]
Percentage of Interest rate for time deposits	1.10%
Maximum [Member]
Percentage of Interest rate for time deposits	1.25%

SCHEDULE OF ACCOUNTS RECEIVABLE

SCHEDULE OF ACCOUNTS RECEIVABLES - RELATED PARTY (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Receivables [Abstract]
Accounts receivable		$ 172,757
Allowance for doubtful accounts
Total		$ 172,757

SCHEDULE OF INVENTORIES (Detail

SCHEDULE OF INVENTORIES (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Finished goods	$ 375,535	$ 589,814

INVENTORIES (Details Narrative)

INVENTORIES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventory write-down	$ 36,241

SCHEDULE OF PREPAID EXPENSES AN

SCHEDULE OF PREPAID EXPENSES AND DEPOSITS (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Prepayments And Deposits
Receivables from sales distributors	$ 115,379	$ 35,302
Deposits to suppliers	301,233	261,068
Subtotal	416,612	296,370
Less: Provision for doubtful accounts	(121,095)
Total	$ 295,517	$ 296,370

SCHEDULE OF CHANGES IN ALLOWANC

SCHEDULE OF CHANGES IN ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Prepayments And Deposits
Beginning balance
Addition	121,514
Write off
Exchange rate effect	(419)
Ending balance	$ 121,095

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Subtotal	$ 505,755	$ 521,463
Less: accumulated depreciation	(289,956)	(223,154)
Total	215,799	298,309
Computer And Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Subtotal	82,298	81,437
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Subtotal	122,185	126,966
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Subtotal	202,570	210,496
Vehicle [Member]
Property, Plant and Equipment [Line Items]
Subtotal	$ 98,702	$ 102,564

PROPERTY AND EQUIPMENT, NET (De

PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation	$ 75,797	$ 55,407

SCHEDULE OF INTANGIBLE ASSETS,

SCHEDULE OF INTANGIBLE ASSETS, NET (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Computer software	$ 34,453	$ 35,801
Less: accumulated amortization	(30,793)	(29,975)
Total	$ 3,660	$ 5,826

INTANGIBLE ASSETS, NET (Details

INTANGIBLE ASSETS, NET (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 1,961	$ 1,505

SCHEDULE OF INVESTMENT IN MARKE

SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Investment In Marketable Securities
Cost of investment	$ 577,035	$ 66,484
Dividend income from Greenpro Capital Corp.	18,939	160,062
Unrealized holding (loss) gain	(505,231)	350,137
Exchange rate effect	(1,742)	352
Investment in marketable securities	$ 89,001	$ 577,035

INVESTMENT IN MARKETABLE SECU_3

INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) - USD ($)	Dec. 31, 2021	Sep. 27, 2021	Dec. 31, 2020	Dec. 09, 2020	Nov. 03, 2020	Oct. 16, 2018	Jul. 30, 2018	May 17, 2018
Investment amount	$ 577,035		$ 66,484
Greenpro Capital Corp. [Member]
Investment in securities, shares						33,333	20	83,333
Investment amount						$ 1,000	$ 125	$ 500,000
Purchased price per shares						$ 0.03	$ 6.2613	$ 6
DSwiss Inc [Member]
Investment in securities, shares				16,663	6,667
Investment amount				$ 83,315	$ 76,671
Purchased price per shares				$ 5	$ 11.50
SEATech Ventures Corp [Member]
Investment in securities, shares		11,665
Investment amount		$ 18,874
Purchased price per shares		$ 1.62

SCHEDULE OF INVESTMENT IN NON M

SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Apr. 03, 2019
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Cost of investment	$ 577,035	$ 66,484
Total investment in non-marketable securities	1,500	1,500
Phoenix Plus Corporation [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Cost of investment	1,500	1,500	$ 1,500
Total investment in non-marketable securities	1,500	1,500
Directors of Unreserved Investments [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Investment in non-marketable securities		730,637
Less: Sale of investment in non-marketable securities		(730,637)
Investment in non-marketable securities

INVESTMENT IN NON-MARKETABLE _3

INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)	3 Months Ended	12 Months Ended
	Mar. 31, 2020USD ($)	Dec. 31, 2021USD ($)shares	Dec. 31, 2020USD ($)shares	Dec. 31, 2021MYR (RM)shares	Mar. 03, 2020	Dec. 31, 2019USD ($)	Apr. 03, 2019USD ($)$ / sharesshares	Mar. 10, 2019
Investment amount		$ 577,035	$ 66,484
Ordinary shares authorized | shares		1,000,000,000	1,000,000,000	1,000,000,000
Proceeds from investments	$ 70,173		$ 70,173
Phoenix Plus Corporation [Member]
Investment amount		1,500	$ 1,500				$ 1,500
Equity interest percentage							5.00%
Shares Issued, Price Per Share | $ / shares							$ 0.0001
Phoenix Plus Corporation [Member] | Common Stock [Member]
Shares purchased during period | shares							15,000,000
Maximum [Member]
Equity interest percentage								20.00%
Minimum [Member]
Equity interest percentage								17.86%
Director [Member]
Investment amount		$ 863,592		RM 3,500,000
Equity interest percentage		20.00%		20.00%
Mr.How Kok Choong [Member]
Investment amount						$ 730,637
Ordinary shares authorized | shares		2,500,000		2,500,000
Amount due from director	$ 660,464
Unreserved Sdn Bhd [Member]
Equity interest percentage					17.86%

SCHEDULE OF OTHER PAYABLES AND

SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Other Liabilities Disclosure [Abstract]
Professional fees	$ 436,541	$ 297,636
Promotion expenses	36,024	37,433
Payroll	22,669	23,976
Commission	219,721	224,711
Others	143,400	63,921
Total	$ 858,355	$ 647,677

SCHEDULE OF RELATED PARTIES (De

SCHEDULE OF RELATED PARTIES (Details) - USD ($)		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Amount due from related parties		$ 7,004	$ 3,235
Amount due from related parties			455
Revenue		6,625	18,060
Purchase		718
Commission expense		12,758	10,740
Other income		$ 4,345	$ 2,881
Agape ATP Asia Limited [Member]
Related Party Transaction [Line Items]
Relationship		Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia	Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia
Nature		Expenses paid for AATP Asia	Expenses paid for AATP Asia
Amount due from related parties		$ 2,214	$ 2,227
Hostastay Sdn Bhd [Member]
Related Party Transaction [Line Items]
Relationship		Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay	Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay
Nature		Sublease rent due from Hostastay	Sublease rent due from Hostastay
Amount due from related parties		$ 4,790	$ 996
TH3 Technology Sdn Bhd [Member]
Related Party Transaction [Line Items]
Relationship		Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology	Mr. How Kok Choong, the CEO and director of the Company is also the director of TH3 Technology
Nature		Expenses paid for TH3 Technology	Expenses paid for TH3 Technology
Amount due from related parties			$ 12
Agape Superior Living Pty Ltd [Member]
Related Party Transaction [Line Items]
Relationship			Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL
Nature			ATP Label Printing Fees
Amount due from related parties			$ 455
Agape Superior Living Pty Ltd ASLPL [Member]
Related Party Transaction [Line Items]
Relationship		Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL	Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL
Nature		Sales of products	Sales of products
Revenue			$ 18,060
Agape Superior Living Pty Ltd ASLPL [Member] | Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Relationship		Mr. How Kok Choong, the CEO and director of the Company	Mr. How Kok Choong, the CEO and director of the Company
Vettons Sdn Bhd One [Member]
Related Party Transaction [Line Items]
Relationship	[1]	Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021	Mr. How Kok Choong, the CEO and director of the Company is appointed as the non-executive Chairman of Vettons Sdn Bhd on February 1, 2021
Nature	[1]	Sales of products made through its platform	Sales of products made through its platform
Revenue	[1]	$ 6,625
Hostastay Sdn. Bhd [Member]
Related Party Transaction [Line Items]
Nature		Sublease rental income due from Hostastay	Sublease rental income due from Hostastay
Revenue	[1]
Commission expense		$ 12,758	10,740
Other income		$ 4,345	$ 2,881
Hostastay Sdn. Bhd [Member] | Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Relationship		Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay	Mr. How Kok Choong, the CEO and director of the Company is also the director of Hostastay
How Kok Choong [Member]
Related Party Transaction [Line Items]
Nature		Commission expense	Commission expense
How Kok Choong [Member] | Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Revenue		$ 6,625
DSY Wellness & Longevity Center Sdn Bhd [Member]
Related Party Transaction [Line Items]
Nature		Purchase	Purchase
Purchase		$ 718
DSY Wellness & Longevity Center Sdn Bhd [Member] | Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Relationship		Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd	Dato’ Sri Yap Foo Ching @ Steve Yap, a director of DSY Wellness International Sdn Bhd, is also a director of DSY Wellness & Longevity Center Sdn Bhd
[1]	During the year ended December 31, 2021, the Company had sales of $ 6,625

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	1 Months Ended		6 Months Ended	12 Months Ended
	Jul. 31, 2020	May 31, 2020	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Preferred stock, shares authorized				200,000,000	200,000,000
Preferred stock, shares issued				0	0
Preferred stock, shares outstanding				0	0
Common stock, shares authorized				1,000,000,000	1,000,000,000
Common stock, shares issued				290,460,047	376,452,047
Common stock, shares outstanding				290,460,047	376,452,047
Business combination, recognized identifiable assets acquired and liabilities assumed, assets				$ 4,105,376
Potentially dilutive securities outstanding				0	0
Share Forfeiture Agreements [Member]
Restructuring Cost and Reserve [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited				85,992,000
Share Forfeiture Agreements [Member] | How Kok Choong Talent Limited [Member]
Restructuring Cost and Reserve [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited				41,750,000
Share Forfeiture Agreements [Member] | How Kok Choong Talent Limited [Member] | Shareholders [Member]
Restructuring Cost and Reserve [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited				44,242,000
Share Forfeiture Agreements [Member] | HKC Holdings Sdn Bhd [Member]
Restructuring Cost and Reserve [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited				11,242,000
ASL [Member]
Restructuring Cost and Reserve [Line Items]
Stock issued during period acquisitions, shares	13,853	162,694	13,853
Business combination, recognized identifiable assets acquired and liabilities assumed, assets			$ 90,043

SCHEDULE OF NON CONTROLLING INT

SCHEDULE OF NON CONTROLLING INTEREST (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Noncontrolling Interest [Abstract]
Paid-in capital	$ 97
Accumulated deficit	(436)
Accumulated other comprehensive income	3
Non Controlling interest Gross	(336)
ASL
Total	$ (336)

SCHEDULE OF COMPONENTS OF INCOM

SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Local – United States	$ (706,659)	$ (735,159)
(Loss) income before income tax	(2,387,613)	516,347
MALAYSIA
Foreign	(1,064,314)	1,070,806
HONG KONG
Foreign	$ (616,640)	$ 180,700

SCHEDULE OF PROVISION FOR INCOM

SCHEDULE OF PROVISION FOR INCOME TAX (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
- Local	$ (22,205)
- Foreign	(104,735)	16,748
- Local
- Foreign	(10,127)	(178,329)
Provision for income taxes	$ (137,067)	$ (161,581)

SCHEDULE OF EFFECTIVE INCOME TA

SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details)	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020
Income Tax Disclosure [Abstract]
U.S. statutory rate	21.00%		21.00%
Valuation allowance	(17.00%)		(4.00%)
Differential tax rate in Malaysia	3.00%		3.00%
Permanent difference	(12.70%)	[1]	11.30%	[2]
Effective tax rate	(5.70%)		31.30%
[1]	The amount comprised: 6.2 6.7
[2]	The amount comprised: 10.2% being expenses incurred in AATP US that were not deductible in the Malaysia tax returns; 0.2% being income derived in AATP HK that were not taxable in the Malaysia tax returns; and 1.3

SCHEDULE OF EFFECTIVE INCOME _2

SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) (Parenthetical)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Tax percentage		10.20%
AATP HK [Member]
Tax percentage	6.20%	0.20%
AATP LB, ASL, SEA, WATP, and DSY [Member]
Tax percentage	6.70%
AATP LB, ASL, SEA and WATP [Member]
Tax percentage		1.30%

SCHEDULE OF DEFERRED TAX ASSETS

SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Less: valuation allowance	$ (380,167)
Depreciation	(15,574)	(68,421)
Deferred tax liabilities, net	(15,574)	(5,743)
UNITED STATES
Net operating loss carry forwards	153,061
Less: valuation allowance	(153,000)	0
MALAYSIA
Net operating loss carry forwards	227,106	62,678
Less: valuation allowance	$ (217,000)	$ 0

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	Jan. 02, 2019	Dec. 31, 2021	Dec. 31, 2020
Operating Loss Carryforwards [Line Items]
Tax percentage		21.00%	21.00%
Income tax examination, description		In addition, the Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax, which is a tax on certain off-shore earnings at an effective rate of 10.5% for tax years (50% deduction of the current enacted tax rate of 21%) with a partial offset for 80% foreign tax credits. If the foreign tax rate is 13.125% or higher, there will be no U.S. corporate tax after the 80% foreign tax credits are applied
Income tax expense benefit		$ 137,067	$ 161,581
Income tax examination penalties and interest expense		395	0
Net operating loss carryforward			312,608
Deferred tax assets operating loss carryforwards		65,648
Cumulative net operating losses		0
Deferred tax valuation allowance		$ 380,167
Tax percentage		(5.70%)	31.30%
Unutilized [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforward		$ 685,000	$ 261,000
UNITED STATES
Operating Loss Carryforwards [Line Items]
Net operating loss carryforward		729,000	0
Deferred tax valuation allowance		$ 153,000	0
Labuan [Member]
Operating Loss Carryforwards [Line Items]
Tax percentage	24.00%
Tax percentage	3.00%
MALAYSIA
Operating Loss Carryforwards [Line Items]
Tax percentage		17.00%
Income tax examination, description		The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000) for the year ended December 31, 2021 and 2020, with the remaining balance being taxed at the 24% rate
Net operating loss carryforward		$ 946,000	261,000
Deferred tax valuation allowance		$ 217,000	$ 0
HONG KONG
Operating Loss Carryforwards [Line Items]
Tax percentage		16.50%
State and Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Tax percentage		21.00%
Foreign Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Tax percentage		35.00%
Domestic Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Income tax expense benefit		$ 22,205

CONCENTRATIONS OF RISKS (Detail

CONCENTRATIONS OF RISKS (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Nov. 30, 2020
Concentration Risk [Line Items]
Deposits	$ 1,112,147	$ 554,864	$ 1,112,147
Deposit for insurance	$ 563,788	$ 295,761	$ 563,788
DSwiss Inc [Member]
Concentration Risk [Line Items]
[custom:DividendShareForCommonStock]	23,330
Proportional of ownership interest and voting power held				0.01%
No Customer [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentrations of risk percentage		10.00%	10.00%
Vendor One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member] | E-commerce [Member]
Concentration Risk [Line Items]
Concentrations of risk percentage			100.00%
Vendor One [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentrations of risk percentage		47.30%	74.10%
Vendor One [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member] | DSwiss Inc [Member]
Concentration Risk [Line Items]
Concentrations of risk percentage		47.30%	74.10%
Vendor Two [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentrations of risk percentage		45.20%	25.90%
One Vendor [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentrations of risk percentage		100.00%
One Sales Distributor [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentrations of risk percentage		17.90%
No Sales Distributor [Member] | Cost of Goods and Service Benchmark [Member] | Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentrations of risk percentage			10.00%

SCHEDULE OF LEASE COMMITMENTS (

SCHEDULE OF LEASE COMMITMENTS (Details)	Dec. 31, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
2022	$ 166,426
2023	84,915
Thereafter
Total lease payments	251,341
Less: interest	(10,763)
Present value of lease liabilities	$ 240,578

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	May 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Apr. 01, 2020
Restructuring Cost and Reserve [Line Items]
Operating lease liability		$ 240,578
Lease expiration term	May 31, 2023
Reduction in ROU assets and liabilities	$ 3,250
Operating lease, rent expenses		$ 179,562	$ 156,716
COVID-19 Impact [Member]
Restructuring Cost and Reserve [Line Items]
COVID-19 impact description		On May 12, 2021, Malaysia was again put under a full lockdown nationwide, until the earlier of (i) daily COVID-19 cases infection of the country fall below 4,000; (ii) intensive Unit Care, or ICU, wards start operating at a moderate level; or (iii) 10% of the Malaysian population is fully vaccinated. The country was administering over 400,000 doses of COVID-19 vaccines daily. On July 17, 2021, the full lockdown was slightly eased as 13.9% of the Malaysian population was fully vaccinated, with another 30% having received at least one dose of the vaccine. The COVID-19 situation in the country showed no sign of abating. Kuala Lumpur and Selangor remained the epicenter of the latest wave of infections. Total COVID-19 cases in the country surpassed the one million mark on July 25, 2021, and daily cases hit a record high of 24,599 on August 26, 2021. Despite the deteriorating COVID-19 state, the government lifted Kuala Lumpur from Enhanced Movement Control Order (“EMCO”) ahead of schedule and ended the nationwide state of emergency on August 1, 2021. Parliament met for the first time this year on July 26, 2021. Malaysia pressed on with its National COVID-19 Immunisation Plan, fast inoculating its residents. COVID-19 infection started to drop below the 10,000 mark daily, beginning October 3, 2021. Effective October 11, 2021, interstate and international travel restrictions were lifted for residents who had been fully vaccinated against COVID-19 as the country achieved its target of inoculating 90% of its adult population. The government is preparing to shift into an endemic COVID-19 phase where it will not impose wide lockdowns even if cases rise. As of March 6, 2022, over 78.9% of the country’s population have been fully vaccinated, with a further 46.0% having received booster shot
Training Center [Member]
Restructuring Cost and Reserve [Line Items]
Lease expiration term	Aug. 31, 2023
ASL [Member]
Restructuring Cost and Reserve [Line Items]
Operating lease liability				$ 490,000
Operating lease effective interest rate	5.50%			5.50%
Operating lease, weighted average remaining lease term		1 year 7 months 20 days

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative)	1 Months Ended
	Jan. 20, 2022USD ($)
Subsequent Event [Member] | Mr.How Kok Choong [Member] | Share Forfeiture Agreement [Member]
Subsequent Event [Line Items]
Company share forfeiture	$ 215,008,035